How severe is CVE-2023-37613?

CVE-2023-37613 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2023-37613 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-37613?

CVE-2023-37613 affects Assemblysoftware Trialworks. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-37613?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2023-37613 published?

CVE-2023-37613 was published on 2023-07-24 and last updated on 2026-06-17.

CVE-2023-37613

CVE-2023-37613 is a medium-severity vulnerability in Assemblysoftware Trialworks with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 6.1)
EPSS exploit prediction: 0% (30th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-79
Affected product: Assemblysoftware Trialworks
Published: 2023-07-24
Last modified: 2026-06-17

Description

A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.

Frequently asked questions

What is CVE-2023-37613?: A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.
How severe is CVE-2023-37613?: CVE-2023-37613 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2023-37613 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-37613?: CVE-2023-37613 affects Assemblysoftware Trialworks. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-37613?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-37613 published?: CVE-2023-37613 was published on 2023-07-24 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:assemblysoftware:trialworks:11.4:*:*:*:*:*:*:*

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →